The global dermatology excimer laser market size was valued at USD 636.07 million in 2025 and is projected to grow from USD 701.84 million in 2026 to USD 1542.06 million by 2034, registering a CAGR of 10.34% during the forecast period from 2026 to 2034. North America dominated the dermatology excimer laser market with a market share of 38.4% in 2025.
Dermatology excimer lasers are medical laser systems that produce concentrated ultraviolet light for treating certain skin conditions. They typically deliver a focused beam to targeted areas of the skin, allowing treatment while minimizing exposure to surrounding healthy tissue. Excimer laser therapy is commonly used in dermatology for conditions such as psoriasis, vitiligo, and other localized skin disorders where controlled ultraviolet treatment may be appropriate. The treatment works by delivering a specific wavelength of light to the affected skin, with the dose adjusted according to the condition and the patient's response. Dermatology excimer lasers are generally used by trained healthcare professionals in clinical settings, with treatment parameters carefully controlled to reduce the risk of skin irritation or excessive UV exposure.
Download a Free Sample To learn more about this report,
Excimer Laser Therapy Expands for Targeted Skin Conditions
The dermatology excimer laser market is increasingly focused on targeted treatments that deliver concentrated ultraviolet light to affected areas while limiting exposure to surrounding healthy skin. Excimer laser systems are widely used by dermatologists for conditions such as vitiligo, psoriasis, and selected cases of alopecia areata. Their ability to deliver controlled treatment to specific lesions makes them attractive when physicians want a more localised approach than broad-area phototherapy.
In February 2025, the U.S. Food and Drug Administration continued recognising excimer laser technology within the broader landscape of light-based dermatological treatments, supporting the established use of targeted phototherapy technologies for selected skin conditions.
Compact and User-Friendly Systems Improve Clinical Treatment
The dermatology excimer laser market is also moving toward systems designed to make treatments more convenient for both clinicians and patients. Manufacturers are focusing on easier treatment positioning, improved energy control, ergonomic handpieces, and more streamlined operating interfaces. These developments can help dermatologists deliver targeted therapy more consistently while supporting the growing use of phototherapy in outpatient dermatology practices.
In October 2025, STRATA Skin Sciences expanded its XTRAC excimer laser platform and related dermatology treatment technologies, focusing on treatment delivery and clinical usability for conditions including vitiligo and psoriasis. The development reflects continued efforts to make targeted phototherapy more practical within routine dermatology care.
Rising Demand for Targeted Phototherapy
The market is being driven by increasing adoption of targeted phototherapy for localized skin disorders such as psoriasis and vitiligo. Excimer systems deliver concentrated UVB energy directly to affected areas, helping minimize exposure to surrounding healthy skin. Growing preference for non-invasive dermatological procedures and more precise treatment approaches is strengthening dermatology excimer laser market demand and supporting growth in targeted skin treatment technologies.
In July 2026, industry analysis highlighted continued adoption of excimer laser systems for psoriasis, vitiligo, atopic dermatitis, and other localized dermatological conditions, supported by advances in precision treatment and patient-focused device design.
High Equipment Costs and Specialized Clinical Requirements
The market faces restraints because advanced excimer laser systems require significant investment in equipment, installation, maintenance, and clinician training. Treatment also typically requires multiple sessions and individualized dose adjustments, which can increase overall healthcare costs. These factors create dermatology excimer laser industry challenges and may limit adoption among smaller clinics and healthcare facilities with restricted capital budgets.
In February 2026, industry analysis identified the historical high cost of excimer laser equipment and specialized treatment requirements as factors influencing adoption, particularly as healthcare providers evaluate investment returns and operational expenses.
Expansion of Handheld and Portable Treatment Systems
The market presents significant opportunities through the development of compact, handheld, and portable excimer laser platforms. Smaller systems can provide greater flexibility for dermatology clinics and enable physicians to target localized lesions more conveniently.
In July 2024, Strata Skin Sciences received approval in Japan for its XTRAC Momentum 1 excimer laser, featuring higher power output, faster repetition rates, a touchscreen interface, and a slim ergonomic design intended to improve treatment efficiency and usability.
Ensuring Consistent Treatment Outcomes and Patient Safety
The market continues to face challenges in maintaining consistent treatment outcomes across different skin conditions, patient characteristics, and treatment protocols. Appropriate UVB dosing must be carefully determined to achieve therapeutic benefits while limiting unwanted skin reactions. Continued clinical research, treatment monitoring, and improved dose-control technologies are therefore important for broader adoption. These requirements are shaping the dermatology excimer laser market outlook and encouraging manufacturers to develop more precise, user-friendly, and clinically adaptable systems.
In January 2026, dermatology research continued to evaluate phototherapy approaches for pediatric skin disorders, identifying excimer laser therapy among available modalities for conditions including psoriasis and vitiligo while emphasizing the importance of condition-specific treatment selection.
Table top Excimer Lasers Segment Dominated the Dermatology Excimer Laser Market with 46.8% Share in 2025
The table top excimer lasers segment dominated the global dermatology excimer laser market with a 46.8% share in 2025, supported by their widespread use in dermatology clinics and specialised treatment facilities. These systems provide precise and controlled laser delivery for targeted skin treatments, making them suitable for managing a range of dermatological conditions.
Hand-held and trolley mounted excimer lasers also contribute to market growth by offering flexibility across different clinical settings. Hand-held systems are gaining adoption due to their portability and ease of use, while trolley mounted systems continue to serve facilities requiring mobile equipment that can be moved between treatment areas.
Request Customizationto receive a tailored report.
Alopecia Areata Segment is Projected to Register the Fastest Growth in the Dermatology Excimer Laser Market at a CAGR of 10.34%
The alopecia areata segment is projected to register the fastest growth in the dermatology excimer laser market at a CAGR of 10.34% during 2026–2034, driven by increasing interest in targeted phototherapy approaches for treating localized hair loss. Growing awareness of dermatological treatment options and the adoption of specialised laser-based therapies are supporting demand within this application.
Psoriasis and vitiligo remain major application areas due to the established use of excimer laser therapy for targeted skin treatment. Atopic dermatitis, allergic rhinitis, and other dermatological conditions also contribute to market expansion as healthcare providers increasingly adopt focused phototherapy technologies for patients requiring specialised treatment.
Speak to an Analystto discuss market opportunities.
North America accounted for the largest share of the global dermatology excimer laser market, representing 38.4% of total revenue and reaching USD 244.25 million in 2025. The region is projected to grow at a CAGR of 8.12% during 2026–2034. Strong dermatology infrastructure, increasing demand for advanced laser-based treatments, growing awareness of targeted skin therapies, and continued investment in specialized medical equipment are supporting regional market growth. The increasing availability of dermatology clinics and specialized treatment centers is also contributing to market expansion.
The US market was valued at approximately USD 209 million in 2025, making it the largest contributor in North America. High demand for advanced dermatological procedures, a well-established network of specialty clinics, and growing adoption of laser-based treatment technologies are supporting market development. Increasing patient awareness and continued investment in modern dermatology equipment are also contributing to demand.
Canada's market reached approximately USD 35 million in 2025. Increasing access to specialized dermatology services, growing awareness of advanced skin treatments, and modernization of clinical equipment are supporting market growth. The expansion of private dermatology clinics is also contributing to market development.
Unlock Regional Insightsto access country-level data, & regional trends.
Asia-Pacific accounted for 23.1% of the global dermatology excimer laser market, reaching USD 146.93 million in 2025, and is projected to register the fastest CAGR of 10.68% during 2026–2034. Expanding healthcare infrastructure, increasing dermatology awareness, rising healthcare expenditure, and growing adoption of advanced aesthetic and therapeutic laser technologies are driving regional growth. Increasing numbers of specialty clinics and greater access to modern dermatological procedures are also supporting market expansion.
China's market was valued at approximately USD 59 million in 2025. Expansion of dermatology clinics, increasing healthcare spending, and growing adoption of advanced laser treatment technologies are supporting market development. Rising awareness of skin disorders and the availability of specialized treatment centers are also contributing to market growth.
Japan's market reached approximately USD 25 million in 2025. An advanced healthcare system, strong demand for specialized dermatology services, and increasing adoption of sophisticated medical laser technologies are supporting market development. Growing interest in precise and minimally invasive dermatological treatments is also contributing to demand.
Europe accounted for 27.6% of the global dermatology excimer laser market, reaching USD 175.56 million in 2025, and is projected to grow at a CAGR of 7.86% during 2026–2034. Established healthcare infrastructure, increasing demand for specialized dermatological treatments, and continued adoption of advanced medical laser systems are supporting regional market growth. Growing awareness of modern treatment options and expansion of specialized clinics are also contributing to market development.
Germany's market was valued at approximately USD 43 million in 2025. Strong healthcare infrastructure, a well-developed dermatology sector, and increasing use of advanced laser treatment technologies are supporting market growth. Continued investment in modern clinical equipment is also contributing to market development.
The UK market reached approximately USD 34 million in 2025. Increasing demand for specialized dermatological care, growing adoption of laser-based treatment technologies, and expanding private healthcare services are supporting market development. Greater awareness of advanced treatment options is also contributing to market growth.
Latin America accounted for 6.2% of the global dermatology excimer laser market, reaching USD 39.44 million in 2025, and is projected to grow at a CAGR of 8.95% during 2026–2034. Improving healthcare infrastructure, increasing access to dermatology services, and growing awareness of advanced skin treatments are supporting regional market development. Expansion of private clinics and increasing adoption of modern medical equipment are also creating opportunities for market growth.
Brazil's market was valued at approximately USD 18 million in 2025. A large dermatology and aesthetic care sector, increasing consumer awareness, and growing adoption of advanced laser technologies are supporting market development. Expansion of specialty clinics is also contributing to market growth.
Mexico's market reached approximately USD 9 million in 2025. Improving access to specialized healthcare, increasing demand for dermatological procedures, and growing adoption of modern laser equipment are supporting market development. Expansion of private dermatology and aesthetic clinics is also contributing to market growth.
Middle East and Africa accounted for 4.7% of the global dermatology excimer laser market, reaching USD 29.90 million in 2025, and is projected to grow at a CAGR of 8.31% during 2026–2034. Healthcare infrastructure development, increasing investment in specialized medical services, and growing awareness of advanced dermatological treatments are supporting regional market growth. Expansion of private hospitals and specialty clinics is also contributing to market development.
The UAE market was valued at approximately USD 7 million in 2025. Advanced healthcare infrastructure, increasing investment in specialty clinics, and growing demand for modern dermatological treatments are supporting market growth. The expansion of private healthcare and medical tourism is also contributing to market development.
Saudi Arabia's market reached approximately USD 9 million in 2025. Healthcare modernization, expansion of specialized medical facilities, and increasing adoption of advanced dermatology technologies are supporting market development. Growing demand for specialized skin treatments and investment in private healthcare services are also contributing to market growth.
The global dermatology excimer laser market is competitive, with medical laser manufacturers developing ultraviolet laser systems for treating dermatological conditions and supporting targeted skin therapies. The top players in the industry include Strata Skin Sciences, Inc., The Daavlin Company, Ra Medical Systems, Shenzhen GSD Tech Co., Ltd., Alma Lasers (Shanghai Fosun Pharmaceutical Group Co., Ltd.), Fotona d.o.o., Beijing Sincoheren S&T Development Co., Ltd., Lumenis, Ltd., Hologic, Inc., DEKA Research & Development Corp., and others.
Industry participants are focusing on improving laser precision, treatment control, patient comfort, and system usability. Companies are also developing compact and versatile platforms that can deliver targeted ultraviolet energy for conditions such as vitiligo, psoriasis, and other localized skin disorders. Advances in beam delivery, treatment customization, and clinical workflow are helping dermatology practices provide more targeted phototherapy while minimizing exposure to surrounding healthy skin.
Strata Skin Sciences, Inc.: An Emerging Market Player
Strata Skin Sciences is a prominent participant in the dermatology excimer laser market, specializing in medical devices for dermatological applications. The company's portfolio includes targeted phototherapy technologies designed to deliver ultraviolet light to affected areas of the skin.
Strata Skin Sciences offers the XTRAC® excimer laser, a targeted ultraviolet phototherapy system used by dermatologists for conditions including psoriasis, vitiligo, and other skin disorders. The system is designed to deliver concentrated UVB energy directly to affected areas, allowing physicians to treat lesions while limiting exposure to surrounding healthy skin. Strata continues to support the platform through clinical applications, treatment protocols, and technology improvements aimed at enhancing dermatology treatment workflows.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Asia Pacific Medical Screws and Plates Market Size, Share by 2034
Urinary Catheters Market Size, Share, Growth, Forecast, 2034
Light Therapy Market Size, Share, Growth, Analysis, Report, 2034
Latin America Cardiac Resynchronization Therapy (CRT) Market Size, Share and Forecast to 2034
Europe Home Infusion Therapy Market Size, 2034
Asia Pacific Home Infusion Therapy Market Size, Share & Trends | Industry Report, 2034
We are featured on:
sales@straitsresearch.com